Yamauchi (Bristol), Matthias (FMI Basel) and Bode (ETH Zurich) labs were awarded a highly competitive €7.6m ERC Synergy Grant for the proposal CHUbVi "Ubiquitin Chains in Viral Infections". This 6-year grant will be used to study the mechanisms of viral infections at the interface of cellular regulation of misfolded proteins and neurodegeneration, with a scope for the development of broadband antiviral treatment strategies in the future. The funding will start in March 2020.